SWOG clinical trial number
S9703
Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Systemic Chemotherapy with CHOP and Local Therapy with Involved Field Radiation in Patients with Malt Lymphomas
Closed
Phase
Accrual
0%
Research committees
Lymphoma
Treatment
Radiation Therapy
clarithromycin
metronidazole
omeprazole
tetracycline
CHOP
RT
Eligibility Criteria Expand/Collapse
Biopsy proven gastric or duodenal mucosa-associated lymphoma tissue (MALT) non-Hodgkin's lymphoma; Stage IE or IIE1; neg. BM biopsy; neg. chest x-ray or scan; positive for H. pylori; no prior chemo or RT for lymphoma; no AIDS or HIV.
Other Clinical Trials
SWOG Clinical Trial Number
S2308
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
Research Committee(s)
Lymphoma
Activated
08/01/2024
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
S2207
Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients with Relapse/Refractory Large B-Cell Lymphoma
Research Committee(s)
Lymphoma
Activated
06/30/2023
Accrual
12%
Open
Phase
SWOG Clinical Trial Number
CTSU/AHOD2131
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Research Committee(s)
Lymphoma
Immunomolecular Therapeutics
Activated
04/28/2023
Open
Phase